EcoDrugPlus

Ensembl ID : ML03711a
Gene Symbol: -
External references: -
219 Possible Orthologues:

Ensembl ID : ML038011a
Gene Symbol: -
External references: -
58 Possible Orthologues:

Ensembl ID : ML038031a
Gene Symbol: -
External references: -
238 Possible Orthologues:

Ensembl ID : ML03873a
Gene Symbol: -
External references: -
113 Possible Orthologues:

Ensembl ID : ML03971a
Gene Symbol: -
External references: -
115 Possible Orthologues:

Ensembl ID : ML04011a
Gene Symbol: -
External references: -
187 Possible Orthologues:

Ensembl ID : ML04042a
Gene Symbol: -
External references: -
23 Possible Orthologues:

Ensembl ID : ML040715a
Gene Symbol: -
External references: -
260 Possible Orthologues:

Ensembl ID : ML040735a
Gene Symbol: -
External references: -
81 Possible Orthologues:

Ensembl ID : ML04123a
Gene Symbol: -
External references: -
167 Possible Orthologues:

Ensembl ID : ML04144a
Gene Symbol: -
External references: -
98 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).